A syringe assembly includes (1) a syringe barrel defining a chamber; (2) a plunger mounted in the chamber and moveable with respect to the barrel; and (3) a cap assembly containing a cap and an absorbent material is removably attached to the plunger. A strip package includes at least two cap assemblies. Each of the cap assemblies includes a cap holder and an antiseptic cap positioned in the cap holder. The antiseptic cap includes a sidewall defining a chamber and an antiseptic substance within the chamber. A strip extends over at least two cap assemblies. The strip includes a first seal engaged to the cap holder and a second seal engaged to the antiseptic cap.

The invention relates to a medical assembly, preferably a sterilized one, comprising a medical article (5) and a package containing said article, said package comprising a hollow support element (2) inside which said article (5) is free, a first protective element (3), called a stopper, which can be coupled to the support element (2) of said article, such that the support element (2) has a grip part (20) that protrudes from said stopper (3), and a second hollow protective element (4), called a cover. Said cover can be coupled to the stopper (3) in such a way as to delimit, in cooperation with said stopper (3), a chamber (8) inside which there extends said grip part (20) of the support element, and, in the state when the cover is coupled to the stopper, a part of the stopper (3) protrudes from the cover (4).

A waste disposal system with a waste receiver for receiving pharmaceutical waste material. A locking assembly is secured to a fixed surface and actuated from a locked configuration to an unlocked configuration. A lock cylinder of the locking assembly may extend forward of a front wall of a receiver body of the waste receiver to engage a locking feature of the cover in the locked configuration. A cover retention feature may prevent axial decoupling of the cover from the receiver body. An engagement feature is moved to be disengaged from the receiver body, and the receiver body is moved away from the fixed surface to disengage the locking assembly from the cover. The cover is decoupled from the cover retention feature, and coupled with the receiver body to seal the pharmaceutical waste material. The locking assembly may be removed from a lock passageway for disposal of the waste receiver.

A waste receiver for receiving pharmaceutical waste material and adapted to be releasably secured to a fixed surface is disclosed. The waste receiver comprises a receiver body with a fluid absorber and a chemical composition disposed within the receiver body. The receiver body defines an opening for receiving the pharmaceutical waste material and comprises an inner surface defining a container volume in fluid communication with the opening, and an outer surface opposite the inner surface with the outer surface defining a lock passageway through the receiver body and a keyway comprising a portion of the lock passageway. The lock passageway is adapted to receive a locking assembly and the keyway is adapted to receive an engagement feature of the locking assembly to releasably secure the waste receiver to the locking assembly in a single orientation. The waste receiver also comprises a cover adapted to be coupled with the receiver body.

A protective container for a sterilized medical implant includes a base including a hollow body having a closed end and an opened end. The base including a thread. A cap is secured about the opened end of the hollow body. The cap includes a thread that cooperates with the thread provided on the base such that relative rotation of the base and the cap causes relative axial movement of the base and the cap. A sealing member is compressed between the base and the cap to provide a seal therebetween as a result of relative axial movement of the base and the cap.

A waste disposal system with a waste receiver for receiving pharmaceutical waste material. A locking assembly is secured to a fixed surface and actuated from a locked configuration to an unlocked configuration. A lock cylinder of the locking assembly may extend forward of a front wall of a receiver body of the waste receiver to engage a locking feature of the cover in the locked configuration. A cover retention feature may prevent axial decoupling of the cover from the receiver body. An engagement feature is moved to be disengaged from the receiver body, and the receiver body is moved away from the fixed surface to disengage the locking assembly from the cover. The cover is decoupled from the cover retention feature, and coupled with the receiver body to seal the pharmaceutical waste material. The locking assembly may be removed from a lock passageway for disposal of the waste receiver.

A syringe assembly includes (1) a syringe barrel defining a chamber; (2) a plunger mounted in the chamber and moveable with respect to the barrel; and (3) a cap assembly containing a cap and an absorbent material is removably attached to the plunger. A strip package includes at least two cap assemblies. Each of the cap assemblies includes a cap holder and an antiseptic cap positioned in the cap holder. The antiseptic cap includes a sidewall defining a chamber and an antiseptic substance within the chamber. A strip extends over at least two cap assemblies. The strip includes a first seal engaged to the cap holder and a second seal engaged to the antiseptic cap.

A package for an object includes a support element with means for coupling the object to the support element. A first hollow protective element is provided as a stopper coupled to the support element of the object. The support element presents a grip portion which projects from the stopper, the support element, alone or in co-operation with the stopper, defining a first chamber containing the object. A second hollow protective element is provided as a cover. The cover is coupled to the stopper so as to cooperate with the stopper to define a second chamber inside which the grip portion of the support element extends. The cover is coupled to the stopper, with the grip portion of the stopper projecting from the cover. The means for coupling is configured to hold the object suspended through the means for coupling, so that the object extends into the space left free between the means for coupling and a bottom portion of the support element. The bottom portion is coupled to the stopper so that the length of the object remain visible.

A pharmaceutical waste disposal assembly (10) for disposing of raw pharmaceutical waste comprises a first receiver body (19) and a first reaction agent (287). The first receiver body (19) receives the pharmaceutical waste. The first receiver body (19) includes a receiver bottom (283). The first reaction agent (287) is positioned within the first receiver body (19) and spaced apart from the receiver bottom (283). The pharmaceutical waste reacts with the first reaction agent (287) to change the pharmaceutical waste in one of a chemical and physical manner so that the pharmaceutical waste is unrecoverable. The first receiver body (19) can receive fluid pharmaceutical waste and/or solid pharmaceutical waste. The first reaction agent (287) may include one or more of a denaturant, an emetic and a bittering agent. For example, the first reaction agent (287) may include one or more of quinine, ipecac and denatonium benzoate.

A pharmaceutical waste disposal assembly (10) for disposing of raw pharmaceutical waste includes a first receiver body and a second receiver body. The assembly further includes a first reaction agent and a second reaction agent. The first reaction agent and the second reaction agent renders the pharmaceutical waste unrecoverable. The first reaction agent can include at least one of a denaturant and a deterrent. Additionally, the first reaction agent can include activated charcoal.